CD
Codexis, Inc.
CDXS · NASDAQ
$1.36 +0.74% (+$0.01)
1M -16.46%
Market Cap $152.7M
P/E Ratio -
Div. Yield -
ROE 74.36%
Piotroski F-Score Weak
3/9Valuation
59 /100
Fair P/S 1.97x
P/B 4.63x
P/E N/A
Growth
0 /100
Declining Rev. growth 20.22%
Book val. growth 29.60%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 83.71%
FCF margin 15.68%
Net margin 39.55%
Quality
8 /100
Poor ROIC 22.74%
Asset turnover 0.65x
ROE 74.36%
Debt
29 /100
High Debt/Equity 2.20x
Int. coverage -22.72x
Current ratio 3.06x
Stability
7 /100
Unstable Beta 2.53x
Profitable years 0
Rev. volatility 34.00%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CDXS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alison Moore
Employees
146
Headquarters
Redwood City
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report